| FunRich: An open access standalone functional enrichment and interaction network analysis tool M Pathan, S Keerthikumar, CS Ang, L Gangoda, CYJ Quek, ... Proteomics 15 (15), 2597-2601, 2015 | 1316 | 2015 |
| Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer AJ Wilson, DS Byun, N Popova, LB Murray, K L'Italien, Y Sowa, D Arango, ... Journal of Biological Chemistry 281 (19), 13548-13558, 2006 | 752 | 2006 |
| PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab M Jhawer, S Goel, AJ Wilson, C Montagna, YH Ling, DS Byun, S Nasser, ... Cancer research 68 (6), 1953-1961, 2008 | 591 | 2008 |
| Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for … JM Mariadason, GA Corner, LH Augenlicht Cancer research 60 (16), 4561-4572, 2000 | 506 | 2000 |
| Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer D Mouradov, C Sloggett, RN Jorissen, CG Love, S Li, AW Burgess, ... Cancer research 74 (12), 3238-3247, 2014 | 463 | 2014 |
| SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer NI Fleming, RN Jorissen, D Mouradov, M Christie, A Sakthianandeswaren, ... Cancer research 73 (2), 725-735, 2013 | 410 | 2013 |
| Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells D Arango, AJ Wilson, Q Shi, GA Corner, MJ Aranes, C Nicholas, M Lesser, ... British journal of cancer 91 (11), 1931-1946, 2004 | 347 | 2004 |
| Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents M Mao, F Tian, JM Mariadason, CC Tsao, R Lemos Jr, F Dayyani, ... Clinical cancer research 19 (3), 657-667, 2013 | 339 | 2013 |
| Genomic and biological characterization of exon 4 KRAS mutations in human cancer M Janakiraman, E Vakiani, Z Zeng, CA Pratilas, BS Taylor, D Chitale, ... Cancer research 70 (14), 5901-5911, 2010 | 320 | 2010 |
| HDACs and HDAC inhibitors in colon cancer JM Mariadason Epigenetics 3 (1), 28-37, 2008 | 300 | 2008 |
| Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin JM Mariadason, D Arango, Q Shi, AJ Wilson, GA Corner, C Nicholas, ... Cancer research 63 (24), 8791-8812, 2003 | 265 | 2003 |
| HDAC4 promotes growth of colon cancer cells via repression of p21 AJ Wilson, DS Byun, S Nasser, LB Murray, K Ayyanar, D Arango, ... Molecular biology of the cell 19 (10), 4062-4075, 2008 | 256 | 2008 |
| Kaiso-deficient mice show resistance to intestinal cancer A Prokhortchouk, O Sansom, J Selfridge, IM Caballero, S Salozhin, ... Molecular and cellular biology 26 (1), 199-208, 2006 | 233 | 2006 |
| Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model JM Mariadason, DH Barkla, PR Gibson American Journal of Physiology-Gastrointestinal and Liver Physiology 272 (4 …, 1997 | 231 | 1997 |
| Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis JM Mariadason, C Nicholas, EL Kaitlin, M Zhuang, HJM Smartt, ... Gastroenterology 128 (4), 1081-1088, 2005 | 225 | 2005 |
| Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation JM Mariadason, M Bordonaro, F Aslam, L Shi, M Kuraguchi, A Velcich, ... Cancer research 61 (8), 3465-3471, 2001 | 218 | 2001 |
| BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival EF Lee, TJ Harris, S Tran, M Evangelista, S Arulananda, T John, ... Cell death & disease 10 (5), 342, 2019 | 179 | 2019 |
| Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors R Gollamudi, MH Ghalib, KK Desai, I Chaudhary, B Wong, M Einstein, ... Investigational new drugs 28, 641-649, 2010 | 171 | 2010 |
| TR3/Nur77 in colon cancer cell apoptosis AJ Wilson, D Arango, JM Mariadason, BG Heerdt, LH Augenlicht Cancer research 63 (17), 5401-5407, 2003 | 158 | 2003 |
| The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG … JK Mooi, P Wirapati, R Asher, CK Lee, P Savas, TJ Price, A Townsend, ... Annals of Oncology 29 (11), 2240-2246, 2018 | 157 | 2018 |
